China SXT Pharmaceuticals, Inc. (SXTC) News

China SXT Pharmaceuticals, Inc. (SXTC)

Today's Latest Price: $0.54 USD

0.00 (-0.83%)

Updated Jul 10 4:00pm

Add SXTC to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 213 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

Filter SXTC News Items

SXTC News Results

Event/TimeSymbolCompanyNews DetailStartEndChangePOWR Rating
Loading, please wait...

Latest SXTC News From Around the Web

Below are the latest news stories about China SXT Pharmaceuticals Inc that investors may wish to consider to help them evaluate SXTC as an investment opportunity.

Hedge Funds Warming Up To China SXT Pharmaceuticals, Inc. (SXTC)

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn't the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F […]

Yahoo | May 29, 2020

China SXT Pharmaceuticals, Inc. Announces That It Received a Grant Supported by City Government

China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements ("TCMHS") announced today that a fund granted to the Company for the key techniques incorporated into advanced Directly-Oral TCMPs derived from agriculture has been approved on February 19, 2020, by the Hailing District Science and Technology Bureau of Taizhou city.

Yahoo | March 16, 2020

How Does China SXT Pharmaceuticals's (NASDAQ:SXTC) P/E Compare To Its Industry, After Its Big Share Price Gain?

China SXT Pharmaceuticals (NASDAQ:SXTC) shares have had a really impressive month, gaining 45%, after some slippage...

Yahoo | January 28, 2020

China SXT Pharmaceuticals, Inc. Announced Regulatory Approval of Its DNA Exam Laboratory

China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements ("TCMHS") announced today that its DNA Exam Laboratory completely built in October of 2019 recently has been approved by Jiangsu province Drug Administration (JSDA). The Laboratory has been granted to perform research and development (R&D;) and quality control of TCM raw materials and TCMP products applying DNA testing technology.

Yahoo | January 16, 2020

China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency

China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company"), (NASDAQ: SXTC) announced today that on December 27, 2019 the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC ("Nasdaq") notifying the Company that the minimum bid price per share for its common shares has been below $1.00 for a period of 30 consecutive business days and the Company therefore no longer meets the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2).

Yahoo | January 3, 2020

What Is China SXT Pharmaceuticals's (NASDAQ:SXTC) P/E Ratio After Its Share Price Tanked?

To the annoyance of some shareholders, China SXT Pharmaceuticals (NASDAQ:SXTC) shares are down a considerable 31% in...

Yahoo | December 4, 2019

Should You Worry About China SXT Pharmaceuticals, Inc.’s (NASDAQ:SXTC) ROCE?

Today we are going to look at China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) to see whether it might be an attractive...

Yahoo | November 14, 2019

China SXT Pharmaceuticals, Inc. Granted to Establish Taizhou Research Center for Advanced TCMP Engineering Techniques

TAIZHOU, China, Sept. 11, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, ...

Yahoo | September 11, 2019

China SXT Pharmaceuticals, Inc. Announces Filing of Annual Report on Form 20-F for Year Ended March 31, 2019

TAIZHOU, China, Aug. 19, 2019 /PR Newswire/ -- China SXT Pharmaceuticals, Inc. (SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), today announced that its Annual Report on From 20-F for the fiscal year ended March 31, 2019 has been filed with the U.S. Securities and Exchange Commission (the "SEC") on August 15, 2019. An electronic copy of the annual report on Form 20-F can be accessed on China SXT's website at http://www.sxtchina.com and on the SEC's website at www.sec.gov. Shareholders may receive a hard copy of China SXT's audited financial statement for the fiscal year ended March 31, 2019 free of charge upon request.

Yahoo | August 19, 2019

China SXT Pharmaceuticals, Inc. Receives New Pharmaceutical GMP Certificate

TAIZHOU, China, Aug. 12, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), announced today that it has been issued a new Certificate of GMP (Good Manufacturing Practice) for Pharmaceutical Products (the "Certificate") by the Food and Drug Administration of Jiangsu Province, China ("FDA"). The FDA staff conducted its on-site examination in accordance with government regulations.

Yahoo | August 12, 2019



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7069 seconds.